Drug – bio-affecting and body treating compositions – Miscellaneous
Patent
1997-11-05
1999-11-16
Weddington, Kevin E.
Drug, bio-affecting and body treating compositions
Miscellaneous
A61K 4700
Patent
active
059859385
ABSTRACT:
A method for reducing oxalate levels in a patient that includes administering to the patient a therapeutically effective amount of non-absorbable amine polymers such as a polymer characterized by a repeat unit having the formula: ##STR1## and salts and copolymers thereof, where n is a positive integer and x is zero or an integer between 1 and about 4.
REFERENCES:
patent: 4143130 (1979-03-01), Imondi et al.
patent: 4198396 (1980-04-01), Seidel et al.
patent: 5244913 (1993-09-01), Coulter et al.
patent: 5607669 (1997-03-01), Mandeville, III et al.
patent: 5618530 (1997-04-01), Mandeville, III et al.
patent: 5624963 (1997-04-01), Mandeville, III et al.
patent: 5679717 (1997-10-01), Mandeville, III et al.
patent: 5693675 (1997-12-01), Mandeville, III et al.
patent: 5703188 (1997-12-01), Mandeville, III et al.
Baggio, B. et al., "Correction of Erythrocyte Abnormalities in Idiopathic Calcium-oxalate Nephrolithiasis and Reduction of Urinary Oxalate by Oral Glycosaminoglycans," The Lancet, 338:403-405 (1991).
Drach, G.W. et al., "The Paradox of Inhibition and Enhancement of the Formation of Urinary Stones," Urological Research, 10 (4) :165-168 (1982).
Scurr, D.S. et al., "Polyanionic Inhibitors of Calcium Oxalate Crystal Agglomeration in Urine," Proc. Eur. Dial. Transplant Assoc. 20:440-444 (1983).
Hagmaier, V. et al., "Prufung der Wirksamkeit eines oxalatbindenden Anionenaustauschers Colestid an gesunden Probanden zum Einsatz bei der idiopathischen Calcium-Oxalat-Urolithiasis", Helvetica Chirurgica Acta, 48: 421-424 (1981). Abstract in English.
Patent Abstracts of Japan, vol. 010, No. 063 (C-332), Mar. 13, 1986 & JP 60 202869 A (Ajinomoto KK), Oct. 14, 1985.
Abstract: WPI Acc. No.: 89-048100/198907 (1989).
Hodgkinson, A., Chapter 8. "Human and Animal Pathology." In Oxalic Acid in Biology and Medicine, (London: Academic Press) pp. 244-253, (1977).
Lindsjo, M. et al., "Treatment of Enteric Hyperoxaluria with Calcium-Contained Organic Marine Hydrocolloid," The Lancet, Sep. 23, 1989, pp. 701-703.
Smith, L.H., M.D. et al., "Acquired Hyperoxaluria, Nephrolithiasis, and Intestinal Disease," The New England Journal of Medicine, vol. 286, Jun. 29, 1972, No. 26, pp. 1371-1374.
Holmes-Farley Stephen Randall
Mandeville, III W. Harry
GelTex Pharmaceuticals Inc.
Weddington Kevin E.
LandOfFree
Method for reducing oxalate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for reducing oxalate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for reducing oxalate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1325430